Title

Ensuring vaccine safety

UMMS Affiliation

Department of Medicine, Division of Infectious Diseases and Immunology; Program in Innate Immunity

Publication Date

2020-12-11

Document Type

Article

Disciplines

Health Services Administration | Health Services Research | Infectious Disease | Patient Safety | Virus Diseases

Abstract

There is an urgent need for vaccines to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to reduce COVID-19 and stop the current pandemic. Although bureaucratic delays should be reduced to accelerate vaccine availability, there remains the need for extensive safety testing protocols developed by the U.S. Food and Drug Administration (FDA) and other regulatory agencies. COVID-19 vaccines will be safe if regulatory agencies maintain their well-documented safety testing protocols. Safety should be considered at every phase of vaccine discovery, development, and testing. History provides a strong scientific basis for safety evaluation of all vaccine candidates, which must be maintained to realize their enormous potential.

Keywords

vaccines, vaccine safety, COVID-19, SARS-CoV-2

DOI of Published Version

10.1126/science.abf0357

Source

Knipe DM, Levy O, Fitzgerald KA, Mühlberger E. Ensuring vaccine safety. Science. 2020 Dec 11;370(6522):1274-1275. doi: 10.1126/science.abf0357. Epub 2020 Nov 17. PMID: 33203781. Link to article on publisher's site

Journal/Book/Conference Title

Science (New York, N.Y.)

Related Resources

Link to Article in PubMed

PubMed ID

33203781

Share

COinS